Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Lewis

Showing results (91-100 of 225) with videos related to

Pageof 23
Sort By:
Diagnostic Microbiology and Infectious Disease|October 20, 2009
Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosisRonen Ben-Ami, P Rocco Lasala, Russell E Lewis, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
The activity of amphotericin B against Candida albicans is not directly associated with extracellular calcium concentrationP David Rogers, Robert E Kramer, Janice K Crews, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignanciesGuillermo Garcia-Effron, Dimitrios P Kontoyiannis, Russell E Lewis, et al.
Medical Mycology|July 31, 2009
Interstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosisRonen Ben-Ami, Gregory A Lamaris, Russell E Lewis, et al.
Medical Mycology|November 23, 2011
Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignanciesLizbeth Cahuayme-Zuniga, Russell E Lewis, Victor E Mulanovich, et al.
Mycoses|August 3, 2013
Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosisRussell E Lewis, Sarah P Georgiadou, Fotis Sampsonas, et al.
Virulence|July 27, 2011
Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infectionRussell E Lewis, Guangling Liao, Weiqun Wang, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2017
Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological MalignanciesMarta Stanzani, Nicola Vianelli, Michele Cavo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 11, 2025
Fungal infections in patients with hematologic malignancies in the pre-triazole era: The dawn of a new era in medical mycologyUmut Akova, Rachel Hicklen, Russell E Lewis, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2022
Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosisArnaldo L Colombo, João N De Almeida, Russell E Lewis, et al.
Pageof 23

Showing results (91-100 of 225) with videos related to

Sort By:
Pageof 23
Diagnostic Microbiology and Infectious Disease|October 20, 2009
Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosisRonen Ben-Ami, P Rocco Lasala, Russell E Lewis, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
The activity of amphotericin B against Candida albicans is not directly associated with extracellular calcium concentrationP David Rogers, Robert E Kramer, Janice K Crews, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignanciesGuillermo Garcia-Effron, Dimitrios P Kontoyiannis, Russell E Lewis, et al.
Medical Mycology|July 31, 2009
Interstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosisRonen Ben-Ami, Gregory A Lamaris, Russell E Lewis, et al.
Medical Mycology|November 23, 2011
Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignanciesLizbeth Cahuayme-Zuniga, Russell E Lewis, Victor E Mulanovich, et al.
Mycoses|August 3, 2013
Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosisRussell E Lewis, Sarah P Georgiadou, Fotis Sampsonas, et al.
Virulence|July 27, 2011
Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infectionRussell E Lewis, Guangling Liao, Weiqun Wang, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2017
Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological MalignanciesMarta Stanzani, Nicola Vianelli, Michele Cavo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 11, 2025
Fungal infections in patients with hematologic malignancies in the pre-triazole era: The dawn of a new era in medical mycologyUmut Akova, Rachel Hicklen, Russell E Lewis, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2022
Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosisArnaldo L Colombo, João N De Almeida, Russell E Lewis, et al.
Pageof 23